Comparison of Mean Duration of Post Operative Analgesia Following QL-2 Block vs QL-3 Block Using Ropivacain 0.25% in Patients Undergoing Unilateral Inguinal Hernia Repair
1 other identifier
interventional
64
1 country
1
Brief Summary
To compare the mean dulation of post operative analgesia following QL2 block (posterior quadratus lumborum block) and the QL3 block (transmuscular quadratus lumborum block) using ropivacaine 0.25% in patients undergoing unilateral inguinai hernia repair. Rationale of the proposed study is to find an optimal approach for quadratus lumborum block (QLB) in the context of local population as no local study has already been carried out for our population. The study seeks to determine which approach provides superior postoperative pain relief and aspires to establish a clear rationale for the application of one technique over the other in local population. By uncovering the strengths and limitations of each approach, the study intends to guide local clinicians in making informed decisions for optimizing postoperative pain management strategies. The outcomes of this study are anticipated to have a substantial impact on clinical practice, potentially leading to improved patient outcomes, reduced opioid consumption, and enhanced patient comfort following inguinal hernia repair surgeries in local settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 28, 2025
CompletedFirst Submitted
Initial submission to the registry
September 22, 2025
CompletedFirst Posted
Study publicly available on registry
September 30, 2025
CompletedOctober 6, 2025
September 1, 2025
6 months
September 22, 2025
September 30, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change in systolic Blood pressure
Baseline, 30 minutes, 2 hours, 4 hours, 8 hours, 12 hours 24 hours
Mean duration of analgesia
assessed using the Visual Analog Score (VAS) ranging tiom 0-10 (0= no pain, l0= the most severe unbearable pain)
Baseline, 30 minutes, 2 hours, 4 hours, 8 hours, 12 hours, 24 hours
Study Arms (2)
QLB-2 (posterior QL block) Group
ACTIVE COMPARATORQLB-3 (transmuscular QL block) Group
ACTIVE COMPARATORInterventions
In the QLB-2 approach, a needle will be inserted in-plane from anterior to posterior, directed towards the posterior QL muscle border, and a 20 ml solution of 0.25% ropivacaine will be injected. For the QLB-3 approach, the needle will be inserted in-plane from anterior to posterior, traversing the QL muscle's proper fascia to target the plane between the QL and PM muscles, and a 20 ml solution of 0.25% ropivacaine will be injected.
Eligibility Criteria
You may qualify if:
- Age between 18 and 50 years ASA status 1 or 2 Scheduled for unilateral inguinal hernia repair under General Anaesthesia
You may not qualify if:
- Patient refusal Patients with pre-existing coagulation abnormalities INR more thnn 1.5 Patients with Strangulated hernia Hypersensitivity to local anaestiretics. Local infection at procedure sito.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bahawal Victoria Hospital, Bahawalpur
Bahawalpur, Punjab Province, 63100, Pakistan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 22, 2025
First Posted
September 30, 2025
Study Start
July 1, 2024
Primary Completion
December 30, 2024
Study Completion
January 28, 2025
Last Updated
October 6, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share